Your session is about to expire
← Back to Search
Behavioural Intervention
Neurolens spectacle lens for Strabismus
N/A
Waitlist Available
Research Sponsored by Neurolens Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-40 days
Summary
This trial is testing special glasses called neurolens for adults aged 18-60 who have trouble with their eyes working together. The glasses have a special prism that helps align the eyes better, reducing strain and discomfort.
Eligible Conditions
- Strabismus
- Convergence Insufficiency
- Digital Eye Strain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30-40 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-40 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Convergence Insufficiency Symptom Score (CISS) questionnaire
Secondary study objectives
Patients with Good Stereoacuity
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeurolensExperimental Treatment1 Intervention
Our proprietary contoured prism lens design, commercially known as neurolens.
Group II: Control lensPlacebo Group1 Intervention
A simple refractive error correction lens
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurolens spectacle lens
2021
N/A
~300
Find a Location
Who is running the clinical trial?
Neurolens Inc.Lead Sponsor
2 Previous Clinical Trials
360 Total Patients Enrolled
Corina Van de Pol, OD, PhDStudy DirectorNeurolens Inc.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger